SCHEMBL29844191

SCHEMBL29844191

COC1(c2cccc(C(=O)N3CC4=C(C3)CN(c3ccc(C(F)(F)F)cc3)C4)c2)COC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 3/20 0.41
▸ POLB P06746 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ NAMPT P43490 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ AKR1C3 P42330 1/20 0.36
▸ RAF1 P04049 1/20 0.36
▸ MRGPRX4 Q96LA9 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ HPGDS O60760 1/20 0.36
▸ HTT P42858 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ ENPP2 Q13822 1/20 0.35
▸ TSHR P16473 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23605488 1.00 EPHX2 (0.41) EPHX2POLBLMNAHPGDNAMPT
SCHEMBL23605586 0.88 NAMPT (0.41) EPHX2HPGDNAMPTSMN1; SMN2MEN1
SCHEMBL29844096 0.86 EPHX2 (0.43) EPHX2POLBLMNAHPGDNAMPT
SCHEMBL23605155 0.86 EPHX2 (0.43) EPHX2POLBLMNAHPGDNAMPT
SCHEMBL23605587 0.86 HCRTR1 (0.42) EPHX2POLBLMNAHPGDSMN1; SMN2
SCHEMBL30045021 0.86 HCRTR1 (0.42) EPHX2POLBLMNAHPGDSMN1; SMN2
SCHEMBL23577517 0.81 LMNA (0.46) EPHX2POLBLMNAHPGDMRGPRX4
SCHEMBL29844010 0.81 LMNA (0.46) EPHX2POLBLMNAHPGDMRGPRX4
SCHEMBL30044850 0.80 EPHX2 (0.38) EPHX2POLBLMNAHPGDSMN1; SMN2
SCHEMBL23605157 0.79 PROKR1 (0.54) POLBLMNAHPGDKMT2AMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081509-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA Zydus Lifesciences Limited (IN) 2022-11-02 — — EP claimed
CN-114901640-A Novel compounds useful for the treatment of dyslipidemia 兹杜斯生命科学有限公司 2022-08-12 — — CN claimed
EP-4081509-A1 NOVEL COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA Zydus Lifesciences Limited (IN) 2022-11-02 — — EP disclosed
CN-114901640-A Novel compounds useful for the treatment of dyslipidemia 兹杜斯生命科学有限公司 2022-08-12 — — CN disclosed
Send feedback